Schmidt, Burkhard C.

[["dc.bibliographiccitation.firstpage","E179"],["dc.bibliographiccitation.issue","10"],["dc.bibliographiccitation.journal","Haematologica"],["dc.bibliographiccitation.lastpage","E181"],["dc.bibliographiccitation.volume","99"],["dc.contributor.author","Mueller-Thomas, Catharina"],["dc.contributor.author","Rudelius, Martina"],["dc.contributor.author","Rondak, Ina-Christine"],["dc.contributor.author","Haferlach, Torsten"],["dc.contributor.author","Schanz, Julie"],["dc.contributor.author","Huberle, Christina"],["dc.contributor.author","Schmidt, Burkhard C."],["dc.contributor.author","Blaser, Rainer"],["dc.contributor.author","Kremer, Marcus"],["dc.contributor.author","Peschel, Christian"],["dc.contributor.author","Germing, Ulrich"],["dc.contributor.author","Platzbecker, Uwe"],["dc.contributor.author","Goetze, Katharina S."],["dc.date.accessioned","2018-11-07T09:34:28Z"],["dc.date.available","2018-11-07T09:34:28Z"],["dc.date.issued","2014"],["dc.identifier.doi","10.3324/haematol.2014.104760"],["dc.identifier.isi","000343038500002"],["dc.identifier.pmid","24972774"],["dc.identifier.purl","https://resolver.sub.uni-goettingen.de/purl?gs-1/14445"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/32174"],["dc.notes.intern","Merged from goescholar"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Ferrata Storti Foundation"],["dc.relation.issn","0390-6078"],["dc.rights","Goescholar"],["dc.rights.uri","https://goescholar.uni-goettingen.de/licenses"],["dc.title","Response to azacitidine is independent of p53 expression in higher-risk myelodysplastic syndromes and secondary acute myeloid leukemia"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dc.type.subtype","letter_note"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]